ADI vs PRLD · P/E 61, rev $11.02B vs rev $6.5M
Analog Devices Inc (ADI) versus Prelude Therapeutics Inc (PRLD) — a side-by-side from cached financials, not a winner call.
Analog Devices Inc (ADI) is a semiconductors company listed on NASDAQ.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
Latest reported ADI revenue for 2025-11-01 was $11.02B. Net income was $2.27B. ADI currently screens at market cap $201.87B and trailing P/E 61.5.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
ADI currently screens at market cap $201.87B and trailing P/E 61.5. PRLD currently screens at market cap $346.5M.
Not investment advice. Open the ADI and PRLD stock pages for the full models.
Not investment advice.